AIL
SRPT icon

AGF Investments LLC’s Sarepta Therapeutics SRPT Stock Holding History

AGF Investments LLC’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,922
Closed -$893K – 510
2021
Q4 		$893K Buy
9,922
+1,954
+25% +$167K 0.08% 84
2021
Q3 		$737K Sell
7,968
-170
-2% -$13.1K 0.07% 53
2021
Q2 		$633K Buy
+8,138
New +$617K 0.07% 115
2019
Q1 		– Sell
-1,311
Closed -$143K – 741
2018
Q4 		$143K Buy
1,311
+311
+31% +$38.9K 0.02% 333
2018
Q3 		$162K Buy
+1,000
New +$137K 0.02% 274

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AGF Investments LLC's SRPT Position: Q1 2022 in Review

AGF Investments LLC sold out of Sarepta Therapeutics (SRPT) in Q1 2022, closing a stake of 9,922 shares — an estimated $893K sold.

AGF Investments LLC first reported a position in SRPT in Q3 2018 and held it in 5 quarters. The position peaked at $893K in Q4 2021. 328 funds tracked by Wall St. Rank hold SRPT as of Q1 2022.

  • AGF Investments LLC reported no remaining Sarepta Therapeutics position as of Q1 2022 after selling out during the quarter.
  • AGF Investments LLC sold 9,922 Sarepta Therapeutics shares in Q1 2022, an estimated $893K.
  • AGF Investments LLC first reported a position in Sarepta Therapeutics in Q3 2018 and held it in 5 quarters.
  • AGF Investments LLC's Sarepta Therapeutics position peaked at $893K in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2022.

Based on AGF Investments LLC's 13F filing for Q1 2022, filed 10 May 2022.